SpringWorks Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	3,360	2,284	1,623	3,052	3,537	1,655
Market Cap Growth	-	40.77%	-46.84%	-13.69%	113.65%	-
Enterprise Value	2,888	1,811	1,035	2,680	3,030	1,327
PE Ratio	-7.03	-7.03	-5.85	-17.55	-77.60	-32.73
PS Ratio	617.03	419.34	-	-	101.05	-
PB Ratio	5.37	3.65	2.91	7.23	6.35	5.14
P/FCF Ratio	-9.92	-9.92	-9.45	-23.50	-107.71	-34.40
P/OCF Ratio	-10.25	-10.25	-10.04	-23.87	-109.86	-34.89
EV/Sales Ratio	530.24	332.54	-	-	86.58	-
EV/EBITDA Ratio	-5.63	-5.63	-3.76	-15.54	-68.60	-22.84
EV/EBIT Ratio	-5.57	-5.57	-3.73	-15.41	-66.49	-22.76
EV/FCF Ratio	-7.87	-7.87	-6.03	-20.63	-92.29	-27.58
Debt / Equity Ratio	0.01	0.01	0.01	0.00	0.00	-
Debt / EBITDA Ratio	-0.02	-0.02	-0.02	-0.01	-0.06	-
Debt / FCF Ratio	-0.03	-0.03	-0.03	-0.01	-0.08	-
Quick Ratio	6.21	6.21	11.61	12.48	28.91	27.42
Current Ratio	6.41	6.41	11.75	12.78	29.15	27.68
Asset Turnover	0.01	0.01	0	0	0.10	0
Return on Equity (ROE)	-65.70%	-65.70%	-59.20%	-36.20%	-12.80%	-33.40%
Return on Assets (ROA)	-57.00%	-57.00%	-53.30%	-34.40%	-12.30%	-26.40%
Return on Capital (ROIC)	-54.16%	-54.16%	-49.81%	-40.94%	-8.28%	-18.39%
Earnings Yield	-9.67%	-14.23%	-17.10%	-5.70%	-1.29%	-3.06%
FCF Yield	-6.85%	-10.08%	-10.59%	-4.26%	-0.93%	-2.91%
Buyback Yield / Dilution	-18.45%	-18.45%	-9.88%	-12.00%	-226.18%	-3792.75%
Total Shareholder Return	-18.45%	-18.45%	-9.88%	-12.00%	-226.18%	-3792.75%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).